View of 973 – Despatil study: a phase ii trial of de-escalated neoadjuvant chemotherapy for early-stage triplenegative breast cancer guided by tumor-infiltrating lymphocytes and radiologic response

Return to Article Details 973 – Despatil study: a phase ii trial of de-escalated neoadjuvant chemotherapy for early-stage triplenegative breast cancer guided by tumor-infiltrating lymphocytes and radiologic response Download Download PDF